inflammatory conditions

Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand
Biotech

Sitala seals $670M deal for Fosun immune disease drug

Right on the heels of a similar deal, Fosun Pharma has outlicensed a second inflammatory disease candidate to a Western biotech startup.
Angus Liu Aug 26, 2025 2:44pm
ducks in a row line up follow leader

Novartis lines up another potential indication for BTK inhibitor

Mar 9, 2024 12:00pm
fightmatch

MoonLake's IL-17 drug wins 'meet or beat' trial vs. competition

Jun 26, 2023 11:18am
Missed target failed trial trial failure

Aclaris stock sinks after phase 2a skin trial flop

Mar 6, 2023 11:29am
Brain Alzheimers question neuro

Manufacturing concerns sideline INmune's US Alzheimer's trial

May 24, 2022 9:44am
Ventus Therapeutics

Chasing Novartis and Roche, Ventus banks $140M for clinical work

Feb 9, 2022 8:12am